Literature DB >> 30020126

Gait Mechanics After ACL Reconstruction Differ According to Medial Meniscal Treatment.

Jacob J Capin1, Ashutosh Khandha1, Ryan Zarzycki1, Kurt Manal1, Thomas S Buchanan1, Lynn Snyder-Mackler1.   

Abstract

BACKGROUND: Knee osteoarthritis risk is high after anterior cruciate ligament reconstruction (ACLR) and arthroscopic meniscal surgery, and higher among individuals who undergo both. Although osteoarthritis development is multifactorial, altered walking mechanics may influence osteoarthritis progression. The purpose of this study was to compare gait mechanics after ACLR among participants who had undergone no medial meniscal surgery, partial medial meniscectomy, or medial meniscal repair.
METHODS: This was a secondary analysis of data collected prospectively as part of a clinical trial. Sixty-one athletes (mean age of 21.4 ± 8.2 years) who had undergone primary ACLR participated in the study when they achieved impairment resolution (5.3 ± 1.7 months postoperatively), including minimal to no effusion, full knee range of motion, and ≥80% quadriceps-strength symmetry. Participants were classified by concomitant medial meniscal treatment: no involvement or nonsurgical management of a small, stable tear; partial meniscectomy; or meniscal repair. Participants underwent comprehensive walking analyses. Joint contact forces were estimated using a previously validated, electromyography-driven musculoskeletal model. Variables were analyzed using a mixed-model analysis of variance with group and limb comparisons (α = 0.05); group comparisons of interlimb differences in measurements (surgical minus contralateral limb) were performed to determine significant interactions.
RESULTS: The participants in the partial meniscectomy group walked with a higher peak knee adduction moment (pKAM) in the surgical versus the contralateral limb as compared with those in the meniscal repair group and those with no medial meniscal surgery (group difference for partial versus repair: 0.10 N-m/kg-m, p = 0.020; and for partial versus none: 0.06 N-m/kg-m, p = 0.037). Participants in the repair group walked with a smaller percentage of medial to total tibiofemoral loading in the surgical limb compared with both of the other groups (group difference for repair versus partial: -12%, p = 0.001; and for repair versus none: -7%, p = 0.011). The participants in the repair group loaded the medial compartment of the surgical versus the contralateral limb 0.5 times body weight less than did the participants in the partial meniscectomy group.
CONCLUSIONS: Participants in the partial meniscectomy group walked with higher pKAM and shifted loading toward the medial compartment of the surgical limb, while participants in the repair group did the opposite, walking with lower pKAM and unloading the surgical limb relative to the contralateral limb. These findings may partially explain the conflicting evidence regarding pKAM after ACLR and the elevated risk for osteoarthritis (whether from overloading or underloading) after ACLR with concomitant medial meniscectomy or repair. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2018        PMID: 30020126      PMCID: PMC6636792          DOI: 10.2106/JBJS.17.01014

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  8 in total

Review 1.  Review of Meniscus Anatomy and Biomechanics.

Authors:  Enzo S Mameri; Suhas P Dasari; Luc M Fortier; Fernando Gómez Verdejo; Safa Gursoy; Adam B Yanke; Jorge Chahla
Journal:  Curr Rev Musculoskelet Med       Date:  2022-08-10

2.  Linking Gait Biomechanics and Daily Steps After ACL Reconstruction.

Authors:  Caroline Lisee; Hope C Davis-Wilson; Alyssa Evans-Pickett; W Zachary Horton; J Troy Blackburn; Jason R Franz; Louise M Thoma; Jeffrey T Spang; Brian G Pietrosimone
Journal:  Med Sci Sports Exerc       Date:  2022-01-24

3.  Operative and nonoperative management of anterior cruciate ligament injury: Differences in gait biomechanics at 5 years.

Authors:  Elizabeth Wellsandt; Ashutosh Khandha; Jacob Capin; Thomas S Buchanan; Lynn Snyder-Mackler
Journal:  J Orthop Res       Date:  2020-03-20       Impact factor: 3.494

4.  Partial medial meniscectomy leads to altered walking mechanics two years after anterior cruciate ligament reconstruction: Meniscal repair does not.

Authors:  Jacob J Capin; Ashutosh Khandha; Thomas S Buchanan; Lynn Snyder-Mackler
Journal:  Gait Posture       Date:  2019-08-27       Impact factor: 2.840

5.  The effect of lateral extra-articular tenodesis on in vivo cartilage contact in combined anterior cruciate ligament reconstruction.

Authors:  Kyohei Nishida; Tom Gale; Daisuke Chiba; Felipe Suntaxi; Bryson Lesniak; Freddie Fu; William Anderst; Volker Musahl
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-02-12       Impact factor: 4.342

6.  Patients With Abnormal Limb Kinetics at 6 Months After Anterior Cruciate Ligament Reconstruction Have an Increased Risk of Persistent Medial Meniscal Abnormality at 3 Years.

Authors:  Tomohiro Shimizu; Alexander R Markes; Michael A Samaan; Matthew S Tanaka; Richard B Souza; Xiaojuan Li; C Benjamin Ma
Journal:  Orthop J Sports Med       Date:  2020-01-23

7.  Preoperative muscle thickness influences muscle activation after arthroscopic knee surgery.

Authors:  Jorge Amestoy; Daniel Pérez-Prieto; Raúl Torres-Claramunt; Juan Francisco Sánchez-Soler; Albert Solano; Joan Leal-Blanquet; Pedro Hinarejos; Joan Carles Monllau
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-12-18       Impact factor: 4.114

8.  α2-macroglobulin-rich serum as a master inhibitor of inflammatory factors attenuates cartilage degeneration in a mini pig model of osteoarthritis induced by "idealized" anterior cruciate ligament reconstruction.

Authors:  Ruipeng Zhao; Xiaochun Wei; Chengming Zhang; Hongru Wu; Chuan Xiang; Haoqian Li; Wangping Duan; Zhiqing Duan; Chunjiang Li; Yu Zhao; Lingan Huang
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.